Research Article
Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests
Table 3
Univariate analysis for therapeutic ERCP (
, 60%).
| | | Odds ratio (OR) | 95% CI for OR | value |
| | Age | 1.01 | [0.99, 1.03] | 0.2914 | | Sex (male versus female) | 0.87 | [0.49, 1.55] | 0.6418 | | Bilirubin (>2 versus ≤2) | 0.06 | [0.35, 1.20] | 0.1668 | | ALT (>56 versus ≤56) | 0.60 | [0.29, 1.25] | 0.1722 | | AST (>40 versus ≤40) | 1.05 | [0.47, 2.34] | 0.8997 | | ALP (>118 versus ≤118) | 1.56 | [0.60, 4.07] | 0.3606 | | GGT (>65 versus ≤65) | 5.06 | [0.94, 27.28] | 0.0590 | | Ultrasound (abnormal versus normal) | 3.76 | [1.16, 12.16] | 0.0272† | | CT scan (abnormal versus normal) | 10.72 | [3.73, 30.80] | <0.0001† |
|
|
Significant result at 0.05 level of significance.
AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma glutamyl transferase; ct: computed tomography.
|
